Phase I/II clinical trial for therapeutic HB vaccine containing HBsAg and HBcAg - Clinical trial for therapeutic HB vaccine

Ehime University Graduate School of Medicine0 个研究点目标入组 71 人开始时间: 2017年5月22日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 71

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The safety of HBsAg/HBcAg containing nasal administrative therapeutic vaccine. Anti-HBs induction and HBsAg reduction were confirmed after administration of the therapeutic vaccine.

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 75years-old（—）
性别: All

入选标准

未提供

排除标准

•severe complication malignancy taking immunosuppresive agents

研究者

发起方

Ehime University Graduate School of Medicine

相似试验

招募中

1 期

Clinical trial of HB vaccine against HBV infectioHBV infection

JPRN-jRCTs061180101Hiasa Yoichi100

终止

1 期

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)Tuberculosis

NCT00440544St George's, University of London9

招募中

2 期

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]Hepatitis B, Chronic

NCT06216470University Health Network, Toronto15

已完成

1 期

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 YearsHepatitis B

NCT05561673GlaxoSmithKline122

已完成

1 期

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in AdultsSARS-CoV-2 Infection

NCT06026514National Institute of Allergy and Infectious Diseases (NIAID)27